Oral Administration
Showing 1 - 25 of >10,000
Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)
Completed
- Parkinson Disease
- Standard LD/CD
- Semi continuous intra-oral administration of LD/CD
-
Rome, ItalyIrccs San Raffaele Pisana
Oct 17, 2022
Diarrhea Infectious Trial (Probiotics administration)
Not yet recruiting
- Diarrhea Infectious
- Probiotics administration
- (no location specified)
Mar 5, 2023
Tranexamic Acid (TXA), Prospective Study, Evidence-based Medicine Trial in Mexico City (Tranexamic Acid Oral Product, Placebo
Completed
- Tranexamic Acid (TXA)
- +3 more
- Tranexamic Acid Oral Product
- Placebo pills
-
Mexico City, MexicoAlejandro Reyes Sánchez
Jan 26, 2023
Labor, Induced, Obesity, Pregnancy Trial in Coimbra (Misoprostol 25 mcg, Misoprostol 50 mcg)
Recruiting
- Labor, Induced
- +3 more
- Misoprostol 25 mcg
- Misoprostol 50 mcg
-
Coimbra, PortugalIolanda João Mora Cruz de Freitas Ferreira
May 10, 2023
Type II Diabetes Trial (CKD-378 (low-dose))
Not yet recruiting
- Type II Diabetes
- CKD-378 (low-dose)
- (no location specified)
May 30, 2023
Healthy Trial in Beijing (JNJ-77242113)
Not yet recruiting
- Healthy
-
Beijing, ChinaPeking University Third Hospital
Jan 20, 2023
Chronic Renal Insufficiency Trial in Sofia (STIRIPENTOL oral administration)
Not yet recruiting
- Chronic Renal Insufficiency
- STIRIPENTOL oral administration
-
Sofia, BulgariaMc Comac Medical
Feb 9, 2023
Vancomycin-Resistant Enterococcal Colonization Trial (VRELysin™, Placebo)
Not yet recruiting
- Vancomycin-Resistant Enterococcal Colonization
- VRELysin™
- Placebo
- (no location specified)
Jan 27, 2023
Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/1,000 mg)
Completed
- Healthy
- CT-L01 12.5/1,000 mg
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Jan 10, 2023
Retinitis Pigmentosa Trial in Tel Hashomer (Alga Dunaliella Bardawil, Placebo (starch))
Active, not recruiting
- Retinitis Pigmentosa
- Alga Dunaliella Bardawil
- Placebo (starch)
-
Tel Hashomer, IsraelSheba Medical Center
Jan 15, 2023
Healthy Participants Trial in Glendale, Brooklyn (AZD4144 Part A, AZD4144 Part B, Placebo Part A)
Not yet recruiting
- Healthy Participants
- AZD4144 Part A
- +3 more
-
Glendale, California
- +1 more
Nov 3, 2023
Healthy Trial (Drug: PF-07817883)
Not yet recruiting
- Healthy
- Drug: PF-07817883
- (no location specified)
Nov 2, 2023
Malignant Tumor Trial in Shanghai (SHR2554)
Completed
- Malignant Tumor
-
Shanghai, Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Dec 16, 2022
Gender Dysphoria Trial (17beta Estradiol)
Not yet recruiting
- Gender Dysphoria
- 17beta Estradiol
- (no location specified)
Aug 2, 2022
Neuropathic Pain, Diabetic Neuropathies, Post Herpetic Neuralgia Trial in Seoul (AJH-2947 100 mg (SAD), Placebo, AJH-2947 200 mg
Recruiting
- Neuropathic Pain
- +2 more
- AJH-2947 100 mg (SAD)
- +9 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 22, 2023
Hypertension Trial (CKD-341, D958)
Not yet recruiting
- Hypertension
- CKD-341, D958
- (no location specified)
Jun 18, 2023
Chronic Cough Trial in Hefei (HRS-2261 tablet?)
Active, not recruiting
- Chronic Cough
- HRS-2261 tablet、placebo
-
Hefei, Anhui, ChinaThe second hospital of Anhui Medical University
Oct 11, 2022
Healthy Adult Subjects Trial in Seoul (ID110521156, Placebo of ID110521156)
Not yet recruiting
- Healthy Adult Subjects
- ID110521156
- Placebo of ID110521156
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 26, 2023